Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Paul Frederick Anderson | CEO, MD & Executive Director | 621.57k | -- | 1966 |
| Ms. Nicole Jane Telford | Chief Financial Officer | -- | -- | -- |
| Mr. Alex McHenry | Chief Operating Officer | -- | -- | -- |
| Prof. Ming Hao Zheng | Chief Scientific Officer and Member of Medical & Scientific Advisory Board | -- | -- | -- |
| Mr. Tony Macintyre | Chief Technical Operations Officer | -- | -- | -- |
| Mr. Peter Gordon Webse B.Bus, FCIS, FCPA, FGIA, M.A.I.C.D. | Company Secretary | -- | -- | 1963 |
Orthocell Limited
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia, the United States, the United Kingdom, and the European Union. The company offers Ortho-ATI, a cell therapy for treatment of chronic tendon injuries; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental procedure; Remplir, a collagen scaffold used in peripheral nerve repair; and Ortho-ACI, an autologous chondrocyte implantation to treat articular cartilage defects in the knee and ankle. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.
Corporate Governance
Upcoming Events
February 24, 2025 at 6:04 AM UTC
Orthocell Limited Earnings Date
Recent Events
Recent Events Information Not Available